Paul F, Freyschmidt J
Rofo. 1976 Jul;125(1):31-7. doi: 10.1055/s-0029-1230410.
In more than 1,000 radiological and endoscopic examinations of the smooth muscle hollow organs of the upper intestinal tract, crysalline glucagon (0.2 to 0.5 mg., average dose 1 u/kg. body weight given at a single intravenous injection) resulted in a significant relaxation and reduction of peristalsis. This effect was less marked in the colon and recto-sigmoid. In five patients with colonic diverticulosis it had no effect. In 150 patients it was found that the onset of hypotonia after injection of glucagon increases from proximal to distal, the duration of maximal reduction in peristalsis decreasing distally. Glucagon is indicated for reducing the tone of smooth muscle hollow organs in order to judge their elasticity and to distinguish between functional and organic causes of a stenosis or increased size of folds. The rapid onset of peristaltic inhibition makes various diagnostic and therapeutic endoscopic procedures simpler or even possible. Compared with the usual atropin-like antispasmodics, glucagon has the advantage of being free from side effects apart from transient hyperglycaemia. Diabetes mellitus requiring insulin is a (relative) contra-indication to the use of glucagon.
在对上消化道平滑肌中空器官进行的1000多次放射学和内镜检查中,结晶胰高血糖素(0.2至0.5毫克,平均剂量为1单位/千克体重,单次静脉注射)可使平滑肌显著松弛并减少蠕动。这种作用在结肠和直肠乙状结肠中不太明显。在5例结肠憩室病患者中,它没有效果。在150例患者中发现,注射胰高血糖素后肌张力减退的发作从近端向远端增加,蠕动最大减少的持续时间向远端缩短。胰高血糖素适用于降低平滑肌中空器官的张力,以判断其弹性,并区分狭窄或皱襞增大的功能性和器质性原因。蠕动抑制的快速发作使各种诊断和治疗性内镜检查程序更简单甚至成为可能。与常用的阿托品样解痉药相比,胰高血糖素除了会引起短暂的高血糖外没有副作用。需要胰岛素治疗的糖尿病是使用胰高血糖素的(相对)禁忌证。